17
Views
21
CrossRef citations to date
0
Altmetric
Anticancer Chemotherapy

Efficacy of Adjuvant Chemotherapy Using Oral Fluorinated Pyrimidines for Curatively Resected Gastric Cancer: A Meta-Analysis of Centrally Randomized Controlled Clinical Trials in Japan

Pages 311-317 | Published online: 18 Jul 2013

References

  • Parkin DM, Bray Fl, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37: S4–S66.
  • Maehara Y, Baba H, Sugimachi K. Adjuvant chemother-apy for gastric cancer: a comprehensive review. Gastric Cancer 2001; 4: 175–184.
  • Saka M, Sasako M, Katai H, et al. Current status and problem of adjuvant chemotherapy for curatively resected gas-tric cancer (in Japanese). Jpn J Cancer Chemother 2000; 27: 2033–2042.
  • Neri B, de Leonardis V, Romano S, et al. Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study. Br J Cancer 1996; 73 (4): 549–552.
  • Alcobendas F, Milla A, Estape J, et al. Mitomycin C as an adjuvant in resected gastric cancer. Ann Surg 1983; 198 (1): 13–17.
  • Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophagealjunction. N Engl J Med 2001; 345: 725–730.
  • Macdonald JS. Clinical overview: adjuvant therapy of gastrointestinal cancer. Cancer Chemother Pharmacol 2004; 54 (Suppl 1): S4–511.
  • Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resection for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. Lancet 1996; 347: 995–999.
  • Sasaki T. In regard to gastric cancer treatment guide-lines - A revised edition. Jpn J Cancer Chemother 2004; 21 (8): 1947–1951.
  • Nakajima T, Ota K, Ishihara S, Oyama S, et al. Meta-analysis of 10 postoperative adjuvant chemotherapies for gas-tric cancer in CIH (in Japanese). Jpn J Cancer Chemother 1994; 21: 1800-1805.
  • Sakamoto J, Morita S, Kodera Y, et al. Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives. Cancer Chemother Pharmacol 2004; 54 (Suppl 1): S25–531.
  • Nakajima T, Nashimoto A, Kitamura M, et al. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomized trial. Gastric Cancer Surgical Study Group. Lancet 1999; 354: 273–277.
  • Nashimoto A, Nakajima T, Furukawa H, et al. Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral fluo-rouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. J Clin Oncol 2003; 21 (12): 2282–2287.
  • Parmar MB, Torn V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998; 17:, 2815–2834.
  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.
  • Gleser II, Olkin I. Stochastically dependent effect sizes. In Cooper H, Hedges LV, eds. The handbook of research synthesis. New York, Russell Sage Foundation, 1994: 340-355.
  • Inokuchi K. Prolonged survival of gastric cancer patients on a specific adjuvant chemotherapy. Jpn J Surg 1984; 14 (5): 351–359.
  • Tanaka T, Nomi S, Naito K, et al. Evaluation of post-operative long-term chemotherapy using FT-207 for the stage III stomach cancer (in Japanese). Jpn J Cancer Chemother 1982; 9 (10): 1765–1770.
  • Yokomori T, Taniguchi T, Iesato H, et al. Postoperative adjuvant chemotherapy using NCS (neocarzinos-tatin) and 5-FU in the treatment of gastric cancer. First report-A comparison with the 5-year survival rate of patients undergoing combined therapy with MMC and 5-FU (in Japanese). Jpn J Cancer Chemother 1987; 14 (11): 3064-3070.
  • Ohmori Y, Kajitani T, Akiyama H, et al. Study of pre-and post-operative chemotherapy with oral 5-FU in patients with gastric cancer. Study Group of Pre- and Post-Operative Oral 5-FU in Gastric Cancer (in Japanese). Jpn J Cancer Chemother 1993; 20 (12): 1781-1789.
  • Nio Y, Hirahara N, Minari Y, et al. Second malignan-cies after a gastrectomy for gastric cancers: the effects of adju-vant therapies. Anticancer Res 1999; 19 (4C): 3591-3599.
  • Honda I, Watanabe S, Fujita Y. Preoperative adjuvant chemotherapy with oral anticancer agents for stomach cancer (in Japanese). Jpn J Cancer Chemother 1997; 24 (9): 1109–1117.
  • Tsugita M, Takasaki K, Yagawa A, et al. An evaluation of perioperative and continuous infusion of tegafur as surgical adjuvant chemotherapy of resected gastric cancer (in Japanese). Jpn J Cancer Chemother 1992; 19 (3): 333–337.
  • Yoshino H, Fujita M, Hirata K, et al. Interim report on JFMTC Study No.21 on Effectiveness of UFT as an Adjuvant Therapy for semi-advanced cancer of the stomach (in Japanese). Jpn J Cancer Chemother 2000; 27 (2): 263-270.
  • Nakajima T, Takahashi T, Takagi K, et al. Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric can-cer. J Clin Oncol 1984; 2 (12): 1366–1371.
  • Fuji' NI, Sakabe T, Wakabayashi K, et al. The optimal period for orally administered fluoropyrimidines as an adjuvant chemotherapy for gastric cancer-a pilot study using 5-FU tablets compared with surgical operation alone (in Japanese). Jpn J Cancer Chemother 1994; 21 (8): 1199–1208.
  • Hermans J and Bonenkamp JJ. Reply to correspon-dence by Pignon, Ducreux, and Rougier and Piedbois and Buyse. J Clin Oncol 1994; 12: 879–880.
  • Earle C, Maroun J. Adjuvant chemotherapy after cura-tive resection for gastric cancer in non-Asian patients: revisit-ing a meta-analysis of randomized trials. Eur J Cancer 1999; 35 (7): 1059–1064.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.